Data on Enfortumab in Post-Platinum and I-O Bladder Cancer

Data on Enfortumab in Post-Platinum and I-O Bladder Cancer

obr

2 months
110 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Bradley McGregor MD, Instructor, Medicine, Harvard Medical School, Clinical Director, Lank Center for Genitourinary Oncology, GU Network Liaison, Dana Farber Cancer Institute explains the data on enfortumab in post-platinum and immuno-oncology (I-O) bladder cancer in patients is impressive enough to possibly change future practice habits.
Up Next Autoplay